Podcasts about Psychopharmacology

This episode includes extended Q&A sessions that address your unanswered questions from the following presentations delivered at the 2025 Spring Congress in Philadelphia, Pennsylvania:  (00:20) All the Tea on ADHD: Guidance for Developing Effective Treatment Strategies for Patients With ADHD by Andrew Cutler, MD   (20:20) You and I and an LAI: Benefits, Early Adoption, and Options for Patients With Serious Mental Illness Desiree Matthews, MSN, PMHNP-BC and Jonathan Meyer, MD (Q&A with Desiree Matthews)   (38:53) A Practical Guide to Ordering and Interpreting Kidney Function Tests by Rajnish Mago, MD   (59:13) Preventing the Progression From Casual to Casualty: An Update on Interventions for Substance Use Disorders by Hara Oyedeji, APRN, PMHNP-BC, MSN, MSEd and Andrew Cutler, MD (Q&A with Hara Oyedeji)    Never miss an episode!

Contact: mentalhealthctr.comRecovery literature (Quit-Lit) Recommendation: Motivational Interviewing: Helping People Change and Grow by William R. Miller PhD, Stephen Rollnick PhD - https://a.co/d/0e0LrSeSong that symbolizes Recovery to Mark: Eye of The Tiger by Survivor - https://youtu.be/btPJPFnesV4?si=ku4iDWLxrhyTUujhIn this episode of The Way Out Podcast, host Jason R.m engages in a deep conversation with Dr. Mark Hrymoc, a psychiatrist specializing in addiction. They explore the multifaceted nature of recovery,the intersection of addiction and mental health, and the importance of treating both simultaneously. Dr. Hrymoc shares insights on innovative treatments like ketamine therapy and the challenges of medications like Suboxone. The discussion also touches on personal reflections about family, success, and the ongoing journey of learning in both personal and professional realms. Dr. Hrymoc emphasizes the importance of reaching out for help and the value of support in the recovery process.TakeawaysRecovery means functioning optimally without limitationsfrom addiction.Addiction and mental health issues often feed off eachother.Both addiction and mental health need to be treatedsimultaneously.Ketamine therapy shows promise for treating depression andanxiety.Suboxone can be challenging to taper off, but a slowapproach can help.Psychopharmacology is focused on treating brain disorderswith medication.Addiction is a lifelong condition that requires management.Family dynamics play a crucial role in addiction recovery.It's important to model humility and communication inrelationships.Struggling with addiction is not a shameful experience. (c) 2015 - 2025 The Way Out Podcast | All Rights Reserved.ThemeMusic: “all clear”(⁠⁠⁠https://ketsa.uk/browse-music/)byKetsa(https://ketsa.uk⁠⁠⁠)licensedunderCCBY-NC-ND4.0(https://creativecommons.org/licenses/by-nc-nd)

Can medication truly transform the landscape of pediatric mental health, or are we oversimplifying the complexities of growing minds? In this episode of Pediatric Meltdown, Dr. Lia Gaggino welcomes Dr. Jess Pierce, a hospital-based child psychiatrist whose expertise bridges the worlds of pediatrics and mental health, especially for children in rural areas. Unraveling the fascinating history of psychopharmacology and delving into the mechanisms of action for the antidepressants, this episode offers a roadmap for pediatricians navigating the maze of SSRIs, SNRIs, risks like serotonin syndrome, and difficult conversations about side effects. The nuances matter and Dr. Pierce guides us skillfully.Discover why family history, patient buy-in, and transparent communications are pivotal to successful treatment—and why prescribing for young people demands a delicate blend of science, art, and empathy. This conversation will change the way you see—and approach—medication and the treatment of kids' mental health.[00:08:51] Exploring Pediatric Psychopharmacology's RootsTracing the unexpected origins of antidepressants, including how tuberculosis and hypertension treatments led to modern psychopharmacologyThe monoamine hypothesis: understanding the neurotransmitter focus in early depression treatmentsThe move beyond serotonin, dopamine, and norepinephrine: new research on neurobiology, neurogenesis, and stress responseProzac's arrival and its impact in reshaping the treatment landscape for pediatric mental health[08:52- 18:06 ] SSRIs in Practice: Similarities, Differences, and SelectionAll SSRIs share rapid absorption, high protein binding, and similar side effect profiles—but key differences can matterImportant reasons to avoid Paxil and to use Lexapro over Celexa, particularly due to side effect burdensNuanced considerations: matching specific SSRIs to individual patient needs, such as Prozac's activating profile for low-energy depressionPractical dosing strategies: the art of balancing “start low and go slow” with the urgency to help suffering children[18:07- 27:59] Navigating Risks, Side Effects, and Patient MonitoringThe truth behind the Black Box Warning: clarifying risks of suicidal ideation vs. the dangers of untreated depressionWhy regular, open conversations with families about medication side effects—especially sexual side effects in teens—build trust and adherenceRecognizing and managing serotonin syndrome: how to spot symptoms and when emergency intervention is neededIdentifying high-risk drug interactions, including situations with migraine or neurology medications[28:00-45:19 ] From SNRIs to the Five-Step Prescribing Approach and BeyondHow SNRIs differ from SSRIs in action, side effects, and indication—especially in pain syndromes or where activating effects are desiredThe use of Wellbutrin as an alternative with fewer sexual side effects, and cautions for seizure-prone populationsStrategic guidelines: the five-step approach to medication choice, considering patient history, family response, symptoms, buy-in, and comorbiditiesCritical cautions with genetic testing and the limitations of using these results to guide first-line medication choices[45:20-1:00:00] Dr Lia's TakeAwaysResources Mentioned:Dr. Pierce's PPT on Pediatric Psychopharmacology Hello! Here's the link to the slides: Psychopharm...

In this episode, Dr. Andy Cutler is joined by Dr. Jennifer Payne to discuss management of mood disorders influenced by fluctuations in reproductive hormones, particularly in women. They explore medication management during the perinatal period, emphasizing the risks associated with inadequately treated mood disorders. The conversation also addresses strategies for managing hormone-related mood disorders across reproductive stages, including premenstrual dysphoric disorder, premenstrual exacerbation, and perimenopausal depression. Jennifer L. Payne, MD is a psychiatrist specializing in reproductive psychiatry and mood disorders in women. She serves as Vice Chair of Research and Professor in the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia, directing the Reproductive Psychiatry Research Program.  Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.

Episode 81 – Janice and Robbie's Story   Robbie is probably one of the most anxious dogs I have seen in my 6 years working as a Veterinary Psychiatrist. His behaviour got so bad that his lovely caregiver, Janice, had to sleep on the sofa with him for several weeks, neither of them getting much sleep. When I first met him, Robbie would pace, pant, patrol the home, lick walls and cupboards, and paw at the floor to try to make himself feel a little better. The relationship with his housemate dogs became extremely tense as they were just not able to read his body language or understand his behaviour. Everyone was stressed and at a loss.   After an initial consultation, I started Robbie on a comprehensive psychopharmaceutical treatment plan and within a few weeks, his anxiety had decreased to the point that Janice could sleep in her own bed again. Robbie continues to go from strength to strength and has even started to play with his toys again and is friends with his housemate dogs again.   Are you a pet parent in a similar situation? Then find me here: www.trinityvetbehaviour.com   Are you a Vet or Pet Care Professional who wants to learn more about Psychopharmacology? Then I have just the thing for you: PSYCHOACTIVE – PRACTICAL VETERINARY PSYCHOPHARMACOLOGY https://katrin-jahn.mykajabi.com/psychoactive   An online course dedicated to teaching you what you need to know to get started on your Veterinary Psychopharmacology Journey!   If you liked this episode of the show, The Pet Behaviour Chat, please LEAVE A 5-STAR REVIEW, like, share, and subscribe!   Facebook Group: Join The Pet Behaviour Community on Facebook   You can CONNECT with me: Website: Visit my website Trinity Veterinary Behaviour Instagram: Follow Trinity Veterinary Behaviour on Instagram Trinity Veterinary Behaviour Facebook: Join us on Trinity Veterinary Behaviour's Facebook page Trinity Veterinary Behaviour YouTube: Subscribe to Trinity Veterinary Behaviour on YouTube LinkedIn Profile: Connect with me on LinkedIn   Thank you for tuning in!

Send us a textThis is another conversation from the Complex Needs Conference 2025 and our guest is Adjunct Associate Professor Danny Sullivan, Consultant Forensic and Adult Psychiatrist.Dr Sullivan gave a keynote at the conference about the prescribing of psychotropic medications, which are namely drugs that influence a person's mood, thoughts, and behavior - for people with complex needs.He is the Board Director of ACSO Australia and Director of Victoria's Sentencing Advisory Council.This episode was recorded at the Complex Needs Conference in Melbourne  co-hosted in March 2025 by ermha365 and ACSO Australia with support from Swinburne University's Centre for Forensic Behavioural Science and funded by the Victoria State Government's Department of Families, Fairness and Housing. ermha365 provides mental health and disability support for people in Victoria and the Northern Territory. Find out more about our services at our website.Helplines (Australia):Lifeline 13 11 14QLIFE 1800 184 52713 YARN 13 92 76Suicide Callback Service 1300 659 467ermha365 acknowledges that our work in the community takes place on the Traditional Lands of many Aboriginal and Torres Strait Islander Peoples and therefore respectfully recognise their Elders, past and present, and the ongoing Custodianship of the Land and Water by all Members of these Communities.We recognise people with lived experience who contribute to GET REAL podcast, and those who love, support and care for them. We recognise their strength, courage and unique perspective as a vital contribution so that we can learn, grow and achieve better outcomes together.

Join Dr. Andy Cutler and Dr. Cynthia Bulik as they discuss the challenges of diagnosing and treating binge eating disorder (BED). They explore the genetics, neurobiology, and clinical course of BED that inform treatment decisions, and examine how advances in genetic research and emerging pharmacological options may improve outcomes for individuals with BED.  Cynthia Bulik, PhD, FAED is a Distinguished Professor of Eating Disorders in the Department of Psychiatry, a Professor of Nutrition in the Gillings School of Global Public Health and the Founding Director of the Center of Excellence for Eating Disorders at the University of North Carolina at Chapel Hill.    Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.    Resources  Eating Disorders Genetics Initiative (EDGI) 2 - edgi2.org  National Eating Disorders Association - nationaleatingdisorders.org  Families Empowered and Supporting the Treatment of Eating Disorders (FEAST) - feast-ed.org   

Are you feeling called to psychedelics? This is your official invitation to a psychedelic magic mushroom retreat with me in Mexico from Sep 10-16. Get all the details ⁠⁠here⁠⁠ and sign up for a free discovery call!My personal experiences with psychedelics have brought me so much healing and expansion! I've reversed my PTSD diagnosis, released shame and my inner critic, ignited my Intuition, and stepped into my power to create a life I LIKE. I share all those details in ep 242.Throughout most of human history, human beings believed in animism, and it doesn't contradict religion (or, it doesn't have to.)Animism is the belief that everything in Nature is alive and has a spirit or consciousness—not just humans and animals, but also trees, rivers, rocks, mountains, and even weather systems.It's one of the oldest belief systems in the world and is found in many Indigenous and earth-based traditions.Animism teaches that the world is made up of relationships - that we're in constant dialogue with the more-than-human world, and that everything is interconnected and deserving of respect.Animism invites us to…listen to and talk to Naturetreat Nature as kin, not a resourcelive in reciprocity, to give to Nature as well as receiveAnimism and relationship with Nature are always available to ALL of us. When we add psychedelics to the mix, especially ones derived from plants and fungi, our perception of how alive and relational Nature is becomes amplified. In a 2019 study published in Journal of Psychopharmacology, participants who took psilocybin (magic mushrooms) reported a 58% increase in their sense of connectedness to nature, and this feeling persisted even two weeks after the experience (Lyons & Carhart-Harris, 2019.) And this study was actually done in a clinical/medical setting, not even in Nature. Whether you're interested in psychedelics or not, this episode will help you deepen your connection to Nature, perfect timing to celebrate Earth Day!EARTH MAGIC WOMEN'S CIRCLEOn Earth Day - Tuesday 4/22 at 6 PM EST - we're having an Earth Magic Celebration on Zoom inside the Wild Wellness Women's Circle.We'll be talking about:myths and creation stories about the Earth being personal and relationalpractical and magical ways to be more connected with Nature - to receive physical and mental health benefits and also to receive messages from your Intuitionhow to see Nature as a mirror for what's happening in our inner world through its cycles of growth and restsome plant medicines and herbs that everyone can start working with, and I'll even pull a plant medicine oracle card personally for YOU!When you join the Wild Wellness Women's Circle…You'll automatically be emailed the Zoom link for this event, plus all upcoming events.You'll also get immediate access to all past live event records, all the self-paced resources, and our daily group chat.If you can't come live, you can watch the replays at YOUR most aligned time, and still make friends and connect in the group chat. Many of us do it this way!Join anytime. Cancel anytime. Name your own price if you need.Free Resources- Feel how you want to feel NOW with my ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Free Desire Map⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠- FREE Masterclass: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Discover Your Spiritual Gifts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠- Sign up for a FREE 1:1 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠coaching curiosity call⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Let's Connect on⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!⁠⁠⁠⁠⁠

Episode 78 – Supporting Pets and Caregivers on their Medication Journey   What are some of the conversations I have with caregivers when it comes to deciding if psychotropic medication in an option for their beloved pet? And what do I discuss with them about the “onboarding” process? How do I manage their expectations and concerns? And what are some of their most frequent worries and how do I address these?   Find out all this an more in this episode!   Are you a Vet or Pet Care Professional who wants to learn more about Psychopharmacology? Then I have just the thing for you: PSYCHOACTIVE – PRACTICAL VETERINARY PSYCHOPHARMACOLOGY https://katrin-jahn.mykajabi.com/psychoactive   An online course dedicated to teaching you what you need to know to get started on your Veterinary Psychopharmacology Journey!   I really hope you enjoy this episode; it is packed with so much information!   If you liked this episode of the show, The Pet Behaviour Chat, please LEAVE A 5-STAR REVIEW, like, share, and subscribe!   Facebook Group: Join The Pet Behaviour Community on Facebook   You can CONNECT with me: Website: Visit my website Trinity Veterinary Behaviour Instagram: Follow Trinity Veterinary Behaviour on Instagram Trinity Veterinary Behaviour Facebook: Join us on Trinity Veterinary Behaviour's Facebook page Trinity Veterinary Behaviour YouTube: Subscribe to Trinity Veterinary Behaviour on YouTube LinkedIn Profile: Connect with me on LinkedIn   Thank you for tuning in!

Join Dr. Andy Cutler and Dr. Carla Sharp as they discuss the current conceptualization of borderline personality disorder (BPD), including diagnostic challenges, evidence-based treatments, and strategies to reduce stigma by framing BPD as a treatable condition. The conversation also covers recent updates to the APA's BPD guidelines.  Carla Sharp, PhD is a distinguished clinical psychologist specializing in developmental psychopathology, particularly borderline personality disorder (BPD). She is a professor in the Clinical Psychology Doctoral Program and serves as the Associate Dean for Faculty and Research at the University of Houston. Additionally, she directs both the Adolescent Diagnosis, Assessment, Prevention, and Treatment Center and the Developmental Psychopathology Lab at the university.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.   

Episode 76 – Choosing Your Psychopharmacology Patient   Would you know which of your patients Behaviour Medication might be indicated for? What are the presentations that could benefit from Behaviour Meds? What are the contexts or situations that might also benefit from the safe and effective use of psychopharmacology?   Have a listen to this episode as I chat about some of the things I think about when evaluating my patients for the potential use of psychotropic medication. Because not every patient is suitable, but for those that are, these medications can be an absolute game changer!   Are you a Vet or Pet Care Professional who wants to learn more about Psychopharmacology? Then I have just the thing for you:   PSYCHOACTIVE – PRACTICAL VETERINARY PSYCHOPHARMACOLOGY https://katrin-jahn.mykajabi.com/psychoactive   An online course dedicated to teaching you what you need to know to get started on your Veterinary Psychopharmacology Journey! Get it at the pre-sale price of just 222 USD until April 24th, 2025 (regular price – 555 USD)   If you liked this episode of the show, The Pet Behaviour Chat, please LEAVE A 5-STAR REVIEW, like, share, and subscribe!   Facebook Group: Join The Pet Behaviour Community on Facebook   You can CONNECT with me: Website: Visit my website Trinity Veterinary Behaviour Instagram: Follow Trinity Veterinary Behaviour on Instagram Trinity Veterinary Behaviour Facebook: Join us on Trinity Veterinary Behaviour's Facebook page Trinity Veterinary Behaviour YouTube: Subscribe to Trinity Veterinary Behaviour on YouTube LinkedIn Profile: Connect with me on LinkedIn   Thank you for tuning in!

Join Dr. Andy Cutler as he speaks with Dr. Anita Clayton about one of the most common yet least discussed side effects of psychotropic medications—sexual dysfunction. They explore the different aspects of sexual dysfunction that may arise as a side effect, how to distinguish these from symptoms of psychiatric or medical disorders, and how to collaborate with patients to effectively address this challenging issue.  Anita H. Clayton, MD, Wilford W. Spradlin Professor and Chair of Psychiatry & Neurobehavioral Sciences, and Professor of Clinical Obstetrics & Gynecology at the University of Virginia School of Medicine, has focused her research on major depressive disorder, mood disorders associated with reproductive-life events in women (reproductive psychiatry), sexual dysfunction related to illness and medications, and the assessment and treatment of primary sexual disorders.    Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.    Resources  Changes in Sexual Functioning Questionnaire short- form (CSFQ-14)  Validation study for CSFQ-14   

Professor David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry. Today we discuss: - What the science says about the effectiveness of anti-depressants.- Evidence based principles for prescribing anti-depressants safely. - Common side effects and withdrawal symptoms. - Do anti-depressants work via so called "emotional numbing" effects?- The use of anti-depressants for other conditions such as OCD and PTSD. - Emerging treatments for depression such as ketamine and psilocybin. - New treatments for psychosis such as KarXT (Cobenfy). Interviewed by Dr. Alex Curmi. Dr. Alex is a consultant psychiatrist and a UKCP registered psychotherapist in-training.If you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line.Give feedback here - thinkingmindpodcast@gmail.com - Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast Tiktok - @thinking.mind.podcast 

Join Dr. Andy Cutler as he speaks with Dr. Christine Moutier about the unintended effects of the FDA boxed warnings on antidepressant use in pediatric patients—specifically, the underdiagnosis and undertreatment of depression. Their conversation highlights the importance of effectively treating depression to reduce suicide across the lifespan.  Christine Yu Moutier, MD is a leading psychiatrist and the Chief Medical Officer at the American Foundation for Suicide Prevention (AFSP). Since joining AFSP in 2013, Dr. Moutier has led a nationwide movement combining scientific research and grassroots efforts to reduce suicide rates. She has testified before Congress, presented at the White House, and frequently contributes to major media outlets on mental health issues.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.    Resources  American Foundation for Suicide Prevention - https://afsp.org/    Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25  Register today at nei.global/spcongress25f    Never miss an episode!

CONTÁCTAME POR WHATSAPP https://wa.me/message/VLBJNM7KBBQDC1 DÉJAME CONOCER TU CASO HACIENDO CLIC AQUÍ https://nelsonarturopsicologo.com/superar-ansiedad Así puedes subir la serotonina de manera natural; y es que, el acelerado ritmo de vida del siglo XXI ha conducido a una búsqueda constante de elementos que faciliten el tener una vida más tranquila, generalmente, bajar los niveles de ansiedad y estrés, poder dormir mejor, son cosas que sin duda se puede que nos haga falta, y para ello es necesario tener niveles estables de serotonina. Este neurotransmisor es el encargado del buen funcionamiento del cerebro aparte de las células nerviosas, permitiendo nivelar las emociones. Teniendo en cuenta estos efectos, hoy te contaremos como regular los niveles de serotonina mediante el suplemento 5HTP. ¿QUÉ ES EL 5 HTP? El 5 hidroxitriptófano popularmente conocido como 5HTP es un precursor de la serotonina, es decir, un elemento vital en la formación de este neurotransmisor. Compra el 5HTP https://iherb.co/Hct3Hehe Existen diversos métodos para su obtención, siendo el más común lógicamente la ingesta de alimentos ricos en él, como la carne de pavo, el pollo, los frijoles, la carne res y bananos; sin embargo, dado los hábitos de alimentación actuales, se ha vuelto complejo añadir alguno de los alimentos anteriormente mencionadas a la dieta diaria, por lo que, una opción para su obtenerlo es mediante la suplementación. ¿POR QUÉ NO SE CONSUME SEROTONINA DE FORMA DIRECTA? Al ser un neurotransmisor que es producido naturalmente por el cuerpo humano, la serotonina es muy diferente a cualquier consumible ya sea por ingesta o por medio intravenosos, la serotonina es incapaz de superar dos barreras de nuestro organismo, la que produce el ácido gástrico, y la producida por la red hematoencefálica. LA DOSIS IDEAL DE 5HTP Se recomienda generalmente. consumir alrededor de 300 mg al día de 5HTP, siempre y cuando la persona tenga características promedio, lo que permitirá producir la serotonina necesaria para contrarrestar afectaciones negativas, como la ansiedad, la falta de sueño, mientras permite gestionar de mejor forma el estrés y regular el apetito. Como ya se ha mencionado en entregas pasadas, para dosificar eficientemente cualquier suplemento es necesario tener presente la estatura, el peso y el problema que se quiere combatir; para mencionar una cosa, puedes contactar con nosotros en Libre de Ansiedad ya que podemos asesorarte si así lo requieres. Es importante señalar que los efectos no son inmediatos, ya que se estima que el 5HTP empieza a tener un impacto significativo en el organismo de una persona entre una a tres semanas de haber empezado la ingesta, ten en cuenta que, en el caso de este potenciador de serotonina, si bien existen testimonios sobre una supuesta efectividad inmediata, suelen ser casos aislados que no representan el efecto normal del suplemento. ENLACES DE INTERÉS (H3) TRIPTÓFANO Y 5HTP PARA CURAR LA ANSIEDAD Y OTROS TRASTORNOS (https://nelsonarturopsicologo.com/triptofano-y-5htp-para-curar-la-ansiedad-y-otros-trastornos/) 7 FORMAS DE SUBIR LA SEROTONINA NATURALMENTE, Y REDUCIR LA ANSIEDAD, LA DEPRESIÓN EL ESTRÉS Y SENTIRTE MEJOR (https://nelsonarturopsicologo.com/7-formas-de-subir-la-serotonina-naturalmente/) REFERENCIAS Boer, J., & Westenberg, H. (1990). Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder. Psychiatry Research, 31, 267-278. https://doi.org/10.1016/0165-1781(90)90096-N. Handley, S., & McBlane, J. (2005). 5HT drugs in animal models of anxiety. Psychopharmacology, 112, 13-20. https://doi.org/10.1007/BF02247358. Maffei, M. (2020). 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. International Journal of Molecular Sciences, 22. https://doi.org/10.3390/ijms22010181. Lesch, K., Bengel, D., Heils, A., Sabol, S., Greenberg, B., Petri, S., Benjamin, J., Müller, C., Hamer, D., & Murphy, D. (1996). Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region. Science, 274, 1527 - 1531. https://doi.org/10.1126/science.274.5292.1527.

Dr. Hoffman continues his conversation with Drew Ramsey, MD, a leading board-certified integrative psychiatrist and author of "Healing the Modern Brain: Nine Tenets to Build Mental Fitness and Revitalize Your Mind."

Navigating Modern Mental Health: Integrative Psychiatry with Dr. Drew Ramsey, a leading board-certified integrative psychiatrist. The conversation addresses the pressing mental health crisis affecting all age groups, from rising Alzheimer's cases among seniors to increasing anxiety and depression in youth. Dr. Ramsey introduces his book, “Healing the Modern Brain: Nine Tenets to Build Mental Fitness and Revitalize Your Mind,” which emphasizes lifestyle changes over medication. They explore the significance of nutritional psychiatry, the effects of modern lifestyle challenges, and the essential tenets for mental fitness. Dr. Ramsey shares his clinical experiences, insights on the benefits of diverse diets, and stresses the importance of movement, purpose, and connection for mental health. The discussion also touches on the challenges and potential of the current health environment, advocating for a balanced and evidence-based approach to mental well-being.

Join Dr. Andy Cutler as he talks with Dr. Jeffrey Strawn about how clinicians can determine the appropriate scenarios for benzodiazepine deprescribing, best practices for benzodiazepine tapering, and how to balance patient preferences to ensure best outcomes.  Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25  Register today at nei.global/spcongress25p  Never miss an episode!

In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Katherine Dahlsgaard review how psychiatric prescribers can incorporate cognitive behavioral therapy (CBT) practices into medication checks with pediatric patients who have anxiety disorders. Specifically, they discuss the importance of using exposures to reduce avoidance behaviors that are characteristic of and feed anxiety disorders. Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center. Katherine Dahlsgaard, PhD, ABPP is a licensed clinical psychologist in Philadelphia, Pennsylvania with expertise in CBT for children, adolescents, and adults. Dr. Dahlsgaard specializes in evidence-based assessment and treatment of anxiety and related disorders.   Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25 Register today at nei.global/spcongress25a   Never miss an episode!

In this episode of Daily Value, we look at the relationship between genetics, habitual caffeine intake, and cognitive performance, using insights from a recent study (PMID: 39648354) in the Journal of Psychopharmacology. Whether you're a "fast" or "slow" caffeine metabolizer could significantly influence how caffeine impacts your brain.Discussion Points:Gene-Caffeine Interactions: how variants in CYP1A2 and ADORA2A genes modulate caffeine metabolism and sensitivity, leading to differential effects on executive function and social cognition.Cognitive Domains: Why slow metabolizers consuming high caffeine outperform fast metabolizers in emotion recognition tasks, and why moderate caffeine enhances executive function in fast metabolizers.Practical Applications: Tailoring caffeine intake based on genetic predisposition to optimize focus, decision-making, and cognitive flexibility.https://pubmed.ncbi.nlm.nih.gov/39648354/Support the show

Join Dr. Andy Cutler as he talks with Dr. Descartes Li about the facts and fiction of electroconvulsive therapy (ECT). They discuss the efficacy and potential side effects of ECT, as well as the importance of educating patients and clinicians on ECT in order to overcome stigma associated with this life-saving treatment.   Descartes Li, MD is a psychiatrist who specializes in caring for patients with bipolar disorder and patients receiving electroconvulsive therapy. He directs the UCSF Bipolar Disorders Program and the UCSF Electroconvulsive Therapy Program. Dr. Li's research interests include bipolar disorder, electroconvulsive therapy and medical education.    Resources  University of California, San Francisco ECT FAQ    Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25  Register today at nei.global/spcongress25f    Never miss an episode!

In this special episode, we present highlights from the PsychopharmaStahlogy Show, hosted by Dr. Andy Cutler and featuring Dr. Stephen Stahl. Join us as we share clips from the most popular episodes of the series, showcasing some of the most though-provoking moments. (01:13) Clip from Treating ADHD Across the Lifespan with Dr. David Goodman (16:16) Clip from Management of Complex Treatment-Resistant Psychotic Disorders with Dr. Michael Cummings (29:31) Clip from Underutilized Psychiatric Drugs: Lithium with Dr. Jonathan Meyer (42:50) Clip from The Antisocial Personality Disorder Spectrum: Diagnosis and Treatment with Dr. James Knoll Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25 Register today at nei.global/spcongress25f Never miss an episode!

In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Robyn Thom discuss the situations in which psychotropic medications are appropriate for children with autism spectrum disorder. They also explore strategies for managing side effects of these medications, including cases involving polypharmacy in this population.   Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.  Robyn Thom, MD is an Assistant Professor at Harvard Medical School and a staff psychiatrist at the Massachusetts General Hospital Lurie Center for Autism. Dr. Thom specializes in treating children and adults with autism spectrum disorder and other neurodevelopmental disorders, anxiety disorders, and mood disorders.  Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25 Register today at https://nei.global/spcongress25p Never miss an episode!

Mark Horowitz is a training psychiatrist, now working as a Clinical Research Fellow at UCL. He is an Associate Editor of the journal Therapeutic Advances in Psychopharmacology and has edited a collection of papers in the journal on Discontinuing PsychiatricMedication. He has a PhD in psychopharmacology and the neurobiology of depression from the Institute of Psychiatry, Psychology and Neuroscience at King's College London. He also co-wrote the Maudsley Deprescribing guidelines.Mark has his own blog https://markhorowitz.org/ and has written in the media about his own personal experiences with antidepressant withdrawal syndrome.Today we discuss:The problems with viewing depression primarily through a biomedical lens The causes of depressionThe limitations of anti-depressants, the risks of withdrawal symptoms when stopping them and Mark's own personal experiences with thisSome useful principles in how to wean off psychiatric medications safely if you are considering doing soInterviewed by Dr. Alex Curmi, consultant psychiatrist and a UKCP registered psychotherapist in-training. If you would like to invite Alex to speak at your organisation please email thinkingmindpodcast@gmail.com with "Speaking Enquiry" in the subject line. If you would like to enquire about an online psychotherapy appointment with Dr. Alex, you can email - alexcurmitherapy@gmail.com.Give feedback here - thinkingmindpodcast@gmail.com -  Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast

In this episode, we explore the critical role of therapeutic alliance in psychopharmacology. We discuss how factors like empathy, communication, and shared decision-making can significantly impact treatment outcomes. Did you know that a doctor's warm voice can increase appointment adherence by 162%? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills Pharmacotherapy Alliance, Treatment Preferences, and Communication

Join Drs. Andy Cutler and Roger McIntyre as they discuss the most significant advancements in psychopharmacology over the past year. Their conversation highlights groundbreaking developments and innovations in the field of psychiatry.  Resources  This Month in Psychopharmacology  Never miss an episode!

In this episode, we explore the science behind the art of psychopharmacotherapy with Dr. David Mintz. We delve into how psychosocial factors, including the prescriber's approach, can significantly impact medication outcomes. Did you know that some psychiatrists achieve better results with placebos than others do with active medications? Faculty: David Mintz, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1 CME: Psychodynamic Psychopharmacology: Alliance, Communication, and Psychotherapy Skills The Science of the Art of Psychopharmacotherapy

In this episode of our special pediatric psychopharmacology series, Dr. Jeffrey Strawn and Dr. Adelaide Robb explore the nuanced use of lithium in treating bipolar disorder among children and adolescents. Their discussion delves into critical aspects of lithium treatment, including carefully calibrated dosing regimens, comprehensive side effect management, and the essential role of parental involvement in treatment decisions.  Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.  Adelaide S. Robb, MD is a psychopharmacologist who specializes in mood disorders, anxiety, and attention deficit disorder. She is Chief of the Division of Psychiatry and Behavioral Sciences at Children's National Hospital in Washington, DC.  Never miss an episode!

In this episode, I dive deep into the fascinating intersections of science and spirituality. Are we all connected in ways that go beyond what we can see or measure? From the mysteries of quantum physics and consciousness studies to the neuroscience behind meditation and near-death experiences, I explore how science is beginning to reveal insights that resonate with ancient spiritual teachings. Join me as I discuss the interconnected nature of reality, the potential for meditation to rewire the brain, and groundbreaking studies on consciousness that challenge conventional ideas about the mind. Whether you're a science enthusiast, a spiritual seeker, or just curious, this episode offers a fresh perspective on the big questions about life, connection, and the universe. References: Quantum Physics and Consciousness: Bohm, David. Wholeness and the Implicate Order. Routledge, 1980. Schrödinger, Erwin. What is Life? Mind and Matter. Cambridge University Press, 1944. Meditation and Neuroplasticity: Lazar, Sara W., et al. "Meditation experience is associated with increased cortical thickness." NeuroReport, 2005. Davidson, Richard J. Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine, 2003. Consciousness Studies and Near-Death Experiences: Van Lommel, Pim. Consciousness Beyond Life: The Science of the Near-Death Experience. HarperOne, 2010. Psychedelic Studies: Griffiths, Roland R., et al. "Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer." Journal of Psychopharmacology, 2016. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, I dive deep into the fascinating intersections of science and spirituality. Are we all connected in ways that go beyond what we can see or measure? From the mysteries of quantum physics and consciousness studies to the neuroscience behind meditation and near-death experiences, I explore how science is beginning to reveal insights that resonate with ancient spiritual teachings. Join me as I discuss the interconnected nature of reality, the potential for meditation to rewire the brain, and groundbreaking studies on consciousness that challenge conventional ideas about the mind. Whether you're a science enthusiast, a spiritual seeker, or just curious, this episode offers a fresh perspective on the big questions about life, connection, and the universe. References: Quantum Physics and Consciousness: Bohm, David. Wholeness and the Implicate Order. Routledge, 1980. Schrödinger, Erwin. What is Life? Mind and Matter. Cambridge University Press, 1944. Meditation and Neuroplasticity: Lazar, Sara W., et al. "Meditation experience is associated with increased cortical thickness." NeuroReport, 2005. Davidson, Richard J. Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine, 2003. Consciousness Studies and Near-Death Experiences: Van Lommel, Pim. Consciousness Beyond Life: The Science of the Near-Death Experience. HarperOne, 2010. Psychedelic Studies: Griffiths, Roland R., et al. "Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer." Journal of Psychopharmacology, 2016. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode includes extended Q&A sessions that address your unanswered questions from the following presentations delivered at the 2024 Congress in Colorado Springs, Colorado:  (00:23) Panic On the Playground! Managing Social Anxiety in Pediatric Patients by Katherine Dahlsgaard, PhD, ABPP and Jeffrey Strawn, MD (Q&A with Dr. Dahlsgaard)   (15:12) Inflammatory Remarks: Our Evolving Understanding of the Role of Inflammation in Mental Health by Roger McIntyre, MD, FRCPC and Vladimir Maletic, MD, MS (Q&A with Dr. McIntyre)   (35:33) Wake Me Up Before You Go-Go: Strategies for Improving Sleep-Wake Issues by Thomas Schwartz, MD   (51:32) Beyond the Blues: Risk, Recognition, and Relief from Perinatal Mood and Anxiety Disorders by Lisa Tremayne, RN, PMH-C, CBC (lisa.tremayne@rwjbh.org)  Never miss an episode!

In this special episode of the NEI Podcast, Dr. Andy Cutler interviews the founder of NEI, Dr. Stephen Stahl about the origins of NEI and the NEI Congress. They also field personal and clinical questions submitted my podcast listeners and NEI members across social media! Tune in for an insightful and fun conversation celebrating 20 years of NEI Congress!  Never miss an episode!

In the first episode of a special pediatric psychopharmacology series hosted by Dr. Jeffrey Strawn, Dr. John Walkup joins the podcast to discuss deprescribing in pediatric patients. The conversation delves into the situations that warrant deprescribing from antidepressants, selecting the right time to do so, and dealing with relapse, as well as much more!  Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.  John T. Walkup, MD is Head of the Pritzker Department of Psychiatry and Behavioral Health at Ann & Robert H. Lurie Children's Hospital of Chicago and a Margaret C. Osterman Professor of Psychiatry and Behavioral Science. He also serves as Director of the Division of Child and Adolescent Psychiatry in the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine.  Never miss an episode!

The prevailing model of psychiatric care in the US is called "med management"-- this typically means a 10-15min appointment to review symptoms and choose medications.  Here Dr. Will Van Derveer of the Integrative Psychiatric Institute sits down with Dr. H to deconstruct this deeply flawed model and posit a more holistic and hopeful way of thinking about psychiatric care. Dr. Van Derveer and the Integrative Psychiatric Institutehttps://psychiatryinstitute.com/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/

This Domestic Violence Awareness Month, we're revisiting an important topic: the often overlooked risk of traumatic brain injury (TBI) among victims of intimate partner violence. Our goal is to shed light on this highly vulnerable group that frequently goes unnoticed in discussions about TBI. By reexamining a previous episode released in March 2020, we aim to raise awareness about the significant dangers faced by those experiencing domestic abuse, particularly the risk of brain injuries resulting from physical violence in intimate relationships.  Deb York, MSN, PMHNP-BC, APRN, CCRA is a board certified Psychiatric-Mental Health Nurse Practitioner practicing in Colorado Springs, Colorado. She completed her research certification as a Certified Clinical Research Associate at the Association of Clinical Research Professionals, and is the Director of Clinical Research at Mountain Mind.    Her research focuses on conducting clinical trials to identify and evaluate novel psychopharmacological and neuroradiological interventions for traumatic brain injury, mood disorders, and pediatric psychiatric illnesses. Deb has over 25 years in the clinical trials industry conducting clinical research in pharmaceuticals & biologics, with a specialty in Women's Health, CNS & psychiatric clinical trials.  Never miss an episode!

Join Dr. Andy Cutler as he talks with Dr. Joan Striebel about the syndrome of catatonia, including its dynamic presentation, treating the underlying disorder, and why clinicians must raise their index of suspicion when evaluating symptoms that could indicate catatonia is present.  Dr. Joan Striebel is a psychiatrist at the California Department of State Hospitals, which is the largest forensic mental health hospital system in the nation.    Resources:  Bush-Francis Catatonia Rating Scale Assessment Resources  Catatonia and Its Treatments  Catatonia: A Clinician's Guide to Diagnosis and Treatment  Catatonia: From Psychopathology to Neurobiology  Guidelines for the management of catatonia    Never miss an episode!

In this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. David Taylor is the Director of Pharmacy and Pathology at Maudsley Hospital and a Professor of Psychopharmacology at King's College in London. He is also the editor-in-chief of the journal Therapeutic Advances in Psychopharmacology. Beyond academia, he contributes significantly to public health policy as a member of the United Kingdom's Department of Transport expert panel that introduced drug-driving regulations. He is also a current member of the UK government's Advisory Council on the Misuse of Drugs and is the only pharmacist to have been made an honorary fellow of the Royal College of Psychiatrists. David is the lead author of the Maudsley Prescribing Guidelines, a role he has held since their inception in 1993. The Maudsley Prescribing Guidelines have achieved significant success, with over 300,000 copies sold across 14 editions and translations into 12 languages. David has also authored 450 clinical papers published in prominent journals such as The Lancet, BMJ, British Journal of Psychiatry, and Journal of Clinical Psychiatry. His work has been cited over 25,000 times. Mark Horowitz is a clinical research fellow in psychiatry at the National Health Service (NHS) in London. He is a Visiting Lecturer in Psychopharmacology at King's College London and an Honorary Clinical Research Fellow at University College London, in addition to being a trainee psychiatrist. Mark holds a PhD from the Institute of Psychiatry, Psychology, and Neuroscience at King's College London, specializing in the neurobiology of depression and antidepressant action. He is the lead author of the Maudsley Deprescribing Guidelines and an associate editor of Therapeutic Advances in Psychopharmacology. Mark co-authored the recent Royal College of Psychiatry's guidance on stopping antidepressants, and his work has informed the recent NICE guidelines on the safe tapering of psychiatric medications, including antidepressants, benzodiazepines, and z-drugs. He has collaborated with the NHS to develop national guidance for safe deprescribing for clinicians and has been commissioned by Health Education England to prepare a teaching module on how to safely stop antidepressants. Mark has published several papers on safe approaches to tapering psychiatric medications, with contributions in The Lancet Psychiatry, JAMA Psychiatry, and Schizophrenia Bulletin. His interest lies in rational psychopharmacology and the deprescribing of psychiatric medications, which is deeply informed by his personal experiences of the challenges associated with coming off psychiatric medications. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2024. Produced by James Moore https://www.jmaudio.org

A new scientific review of academic research on cannabis and human sexuality concludes that while the relationship between marijuana and sex is a complicated one, use of cannabis is generally associated with more frequent sexual activity as well as increased sexual desire and enjoyment. The article, published this week in the journal Psychopharmacology, also suggests that lower doses of marijuana may actually be best suited for sexual satisfaction, while higher doses could in fact lead to decreases in desire and performance. And it suggests the effects may differ based on a person's gender. Reports suggest that cannabis has the potential to enhance sexual pleasure, reduce inhibitions, alleviate anxiety and shame, and promote intimacy and connection with sexual partners,” wrote the five-author research team from The Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel. “Furthermore, it has been associated with increased pleasure during masturbation and enhanced sensory experiences during sexual encounters. These observations indicate that cannabis may have notable effects on sexual experiences. Cannabis Talk 101, “The World's #1 Source For Everything Cannabis”, made global history by becoming the first cannabis show to partner with iHeartMedia, on 4/20/2020. Thank you for listening & watching Cannabis Talk 101 with Christopher Wright, aka "Blue" the CEO and creator of Cannabis Talk 101 and the Cannabis Talk Network. & Joe Grande, former Co-Host on Big Boy's Neighborhood on Power 106 FM, On-Air with Ryan Seacrest on 102.7 KIIS FM in Los Angeles and The Dog House in the Bay Area on WILD 94.9 KYLD. FOX SPORTS, NBC SPORTS. Financial Fridays with Tony Kassaei, The Inside Investor, 40 TONS TALK, WITH ANTHONY SLIMBURG, CHRONIC HISTORY WITH HISTORY CONNOR V. Toking with the Stars with Chuckie & Marty, & on YouTube, IHeartRadio App, Spotify, & Apple Podcasts. See omnystudio.com/listener for privacy information.

Join us and special guest Dr. Jason Cafer, author of Cafer's Psychopharmacology, for a Q&A on antipsychotics and schizophrenia. For more information visit: https://www.cafermed.com/ Answer to poll question below (SPOILER) ————————————————— Answer: Option B: B Vitamins. --- Support this podcast: https://podcasters.spotify.com/pod/show/psychrounds/support

Matthew W. Johnson, PhD, is a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt's Institute for Advanced Diagnostics and Therapeutics. He is one of the world's most accomplished scientists on the human effects of psychedelics and has conducted seminal research in the behavioral economics of drug use, addiction, and risk behavior. Dr. Johnson, an expert in behavioral pharmacology research, has decades of experience. In his most recent role, he served as a professor of psychiatry and behavioral sciences at Johns Hopkins Medicine. Dr. Johnson's current research centers around the efficacy and safety of psychedelics in the treatment of various medical and mental health conditions.  In 2008, Dr. Johnson played a crucial role in revitalizing human psychedelic research by publishing psychedelic risk and safety guidelines, which are now widely recognized as field standards. His trials have explored the effects of psychedelics on mystical experience, personality change, cancer distress treatment, and depression treatment. Dr. Johnson published the first research on psychedelic treatment for tobacco addiction in 2014. In 2021, he received the first federal grant in a half-century for treatment research with a classic psychedelic. He has received continuous National Institute of Health (NIH) funding as Principal Investigator since 2009 and has reviewed for >75 journals, including serving as guest editor on two special issues on psychedelics. Dr. Johnson has reviewed grants for the NIH, the National Science Foundation, the U.S. Military, and multiple governments outside the U.S. He was a member of the Addictions Risks and Mechanisms (ARM) NIH study section for 5 years. He has been invited to present his research in over a dozen countries. Dr. Johnson holds a Bachelor of Science degree from Eastern Oregon University and earned his PhD in Experimental Psychology from the University of Vermont. He served as President of the International Society for Research on Psychedelics in 2020, the first scientific society dedicated to quantitative research on psychedelics and one he played a role in founding. In 2019, Dr. Johnson also served as President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association.  Dr. Johnson has been interviewed about psychedelics and other drugs by many newspapers, TV and radio programs, and podcasts around the world. These include interviews by Anderson Cooper on 60 Minutes, CNN, NPR, Fox News, Fox Business News, the BBC, The New York Times, The Washington Post, The Wall Street Journal, The Globe and Mail, The Atlantic, Newsweek, Vanity Fair, Marie Claire, Vogue, Washingtonian, Scientific American, Nature, the Lex Fridman Podcast, the Huberman Lab Podcast, Big Think, and by Michael Pollan in his best-selling book, How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence. Follow Dr. Johnson X: https://x.com/drug_researcher Website: https://www.sheppardpratt.org/why-sheppard-pratt/our-experts/details/matthew-w-johnson-phd/   The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.

DMT and Ayahuasca? What's the difference? What are they? Jim couldn't even fake his way through these questions. Good thing our podcast shaman Professor David Nutt was here to guide Jim his Ayahuasca journey. IDKAT Live Show on May 21 @ 8pm in Los Angeles: https://www.flapperscomedy.com/shows/jim-jefferies-live-podcast-taping/69867/ BIO: Prof. David Nutt is the Founder of Drug Science and the Edmund J Safra Professor of Neuropsychopharmacology. He serves as the Head of the Neuropsychopharmacology Unit in the Centre for Academic Psychiatry within the Division of Brain Sciences, Department of Medicine, at Hammersmith Hospital, Imperial College London. He has also chaired the UK Advisory Council on the Misuse of Drugs. For over twenty-five years, Prof Nutt has served as the editor of the Journal of Psychopharmacology, and he acts as a psychiatry drugs advisor to the British National Formulary. He has written over 500 original research papers and 31 books. Notably, his book for the general public, 'Drugs Without the Hot Air' , earned him the Transmission book prize in 2014 for Communication of Ideas. Twitter: @ProfDavidNutt The Drug Science Podcast - https://www.drugscience.org.uk/podcast ADS: LITTER ROBOT: As a special offer to listeners of the show, go to http://stopscooping.com/IDKAT and enter promocode IDKAT to save an EXTRA $50 on any Litter-Robot bundle.  LECTRIC eBIKES: Get your adventure started at http:/www.LectricEbikes.com. And please mention that I Don't Know About That With Jim Jefferies sent you in the post-checkout survey! BETTERHELP: Visit http://www.BetterHelp.com/IDK today to get 10% off your first month. CHAPTERS: 0:00 — Ads 2:20 — Theme Song 12:27 — Judging a Book by It's Cover 14:37 — David Nutt Introduction 18:35 — Questions 24:08 — Jim's Ayahuasca Diet 26:55 — Ads 38:47 — Grading 39:43 — Answers 44:28 — The Great Tradition 50:30 — How Old Is Too Old? 1:13:25 — Australian Ayahuasca Guide 1:14:33 — Dinner Party Fact